Overview of molecular subtype of medulloblastoma and role of MRI in their identification
- 11 October 2022
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Radiology and Radiation Oncology
- Vol. 8 (1), 005-010
- https://doi.org/10.17352/ijrro.000048
Abstract
Medulloblastoma is the most prevalent malignant brain tumor in children, accounting for roughly 15% to 20% of all malignancies of the Central Nervous System (CNS), for 40% of childhood, tumors are in the posterior fossa. Medulloblastoma is a heterogeneous combination of several subgroups with discrete characteristics, rather than a homogeneous illness. Genomic profiling of medulloblastomas revealed that the medulloblastoma may be further divided into four separate molecular subgroups. In this review, we aim to focus on the current state of understanding of the molecularity of the disease with a focus on genomic events that define the aforementioned subgroups and an overview of the molecular subtype of medulloblastoma upon discussing the following points (i) introduction to medulloblastoma and basic classification of the molecular subtype of medulloblastoma followed by their prevalence, age and gender discrimination, and specific molecular characterization. (ii) specific MRI features of the locality of a molecular subtype of medulloblastoma (iii) finally MRI distinguishable features for the identification of the specific molecular type. This review will enhance your knowledge regarding the subtype of medulloblastoma and the role of MRI in the identification of these subtypes.Keywords
This publication has 37 references indexed in Scilit:
- Paediatric intra-axial posterior fossa tumours: pictorial reviewHeart, 2012
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- A Mouse Model of the Most Aggressive Subgroup of Human MedulloblastomaCancer Cell, 2012
- Subtypes of medulloblastoma have distinct developmental originsYearbook of Pathology and Laboratory Medicine, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesActa Neuropathologica, 2011
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical OutcomeJournal of Clinical Oncology, 2011
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsActa Neuropathologica, 2011
- Le médulloblastome de l’enfantArchives de Pédiatrie, 2008
- β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour CommitteeJournal of Clinical Oncology, 2005